|
Dr. Whoriskey joined Momenta at its inception. Previously, she was Senior Director of Licensing at Cubist Pharmaceuticals, Inc., where she was involved in negotiating collaborations with Merck, Pfizer, Novartis and Bristol Myers Squibb as well as the in-licensing of the company's key product from Eli Lilly, daptomycin. In her role as Senior Director, she was also responsible for overseeing the company's intellectual property estate. | 